Medivation Inc. continues to thwart Sanofi's attempts to take over the oncology company, urging shareholders to reject Sanofi's "maneuver" to replace its board of directors.
Medivation sent a letter to shareholders on June 23 laying out the false claims that its potential acquirer has made....




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
